Emilio Arteaga-Solis

Title: Emilio Arteaga-Solis: Innovator in Aging Research

Introduction

Emilio Arteaga-Solis is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of aging research, particularly in the treatment of frailty associated with aging. His innovative approach focuses on the modulation of specific signaling pathways to improve health outcomes in mammals, especially humans.

Latest Patents

Emilio Arteaga-Solis holds a patent titled "Osteocalcin as a treatment for frailty associated with aging." This patent outlines methods and compositions for treating frailty in mammals. The methods involve modulation of the OST-PTP signaling pathway or the PTP-1B signaling pathway, utilizing gamma-carboxylase and osteocalcin. The administration of undercarboxylated or uncarboxylated osteocalcin is central to these methods. The patent aims to alleviate muscle wasting or lung disorders while also addressing metabolic, male reproductive, or cognitive disorders. He has 1 patent to his name.

Career Highlights

Emilio Arteaga-Solis is affiliated with Columbia University, where he conducts research and develops innovative treatments. His work is pivotal in understanding the biological mechanisms of aging and frailty. His research has the potential to significantly impact the quality of life for aging populations.

Collaborations

Emilio collaborates with esteemed colleagues such as Gerard Karsenty and Paula Mera. These partnerships enhance the depth and breadth of his research, contributing to advancements in the field of aging and health.

Conclusion

Emilio Arteaga-Solis is a pioneering inventor whose work in aging research is making strides in the treatment of frailty. His innovative methods and collaborations position him as a key figure in the ongoing quest to improve health outcomes for the aging population.